Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
04/2014
04/02/2014CN102911157B (E)-3-[2-bromo-5-(3-substituted propoxy)]phenyl-N-{4-methyl-3-[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl acrylamide compound
04/02/2014CN102899032B Electropolymerizable fluorescent sensing material and application on fluorescent or electropolymerizable detection of metal ions
04/02/2014CN102712623B Hepatitis c virus inhibitors
04/02/2014CN102633780B Nitric oxide donor with thrombin inhibition effect, as well as preparation method and medical application thereof
04/02/2014CN102584790B S-pantoprazole sodium trihydrate, and preparation method and application thereof
04/02/2014CN102498105B Bicyclic compound and use thereof for medical purposes
04/02/2014CN102438996B Histone deacetylase inhibitors with branched structure synthesized through click chemistry
04/02/2014CN102421769B Vinyl indazolyl compounds
04/02/2014CN102311729B Electrochromic material, preparation method thereof, glare-proof rearview mirror for automobiles
04/02/2014CN102264722B Dihydropyridone amides as p2x7 modulators
04/02/2014CN102212058B Single composite medicament (chiral nitrogenous heterocyclic ester) and synthesis method thereof as well as application of chiral nitrogenous heterocyclic ester in preparing low-toxicity CB1 receptor inhibitor
04/02/2014CN102060841B Acylhydrazone containing heterocyclic amide structure, oxime ester compound and application thereof
04/02/2014CN102050815B Dabigatran ester derivatives as prodrug
04/02/2014CN102046608B 3,4-dihydropyrimidine TRPA1 antagonists
04/02/2014CN101659658B Quinoline substituted by cyan
04/02/2014CN101497606B Preparation of rupatadine or salt thereof
04/02/2014CN101466702B Anthranilic acid diamide derivative with hetero-aromatic and hetero-cyclic substituents
04/01/2014US8686156 Thiazole derivatives as pesticides
04/01/2014US8686155 Aurora kinase modulators and method of use
04/01/2014US8686153 Lenalidomide salts
04/01/2014US8686143 Compounds useful as inhibitors of Janus kinases
04/01/2014US8686009 Prodrugs of NH-acidic compounds
04/01/2014US8686005 Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
04/01/2014US8686004 Heterocyclic compounds as pesticides
04/01/2014US8686002 Heterocyclic compounds and their use as binding partners for 5-HT5 receptors
04/01/2014US8685986 Medical composition for treatment or prophylaxis of glaucoma
04/01/2014US8685985 Selective insecticides based on anthranilic acid diamides and safeners
04/01/2014US8685972 Pyrimidine derivatives for treatment of alzheimer's disease
04/01/2014US8685971 Quinolinyloxyphenylsulfonamides
04/01/2014US8685960 6-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase CYP11B2
04/01/2014US8685959 Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
04/01/2014US8685543 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
04/01/2014CA2770766C Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]-1h-indol-3-yl]-methanones
04/01/2014CA2654515C Substituted 3-cyanopyridines as protein kinase inhibitors
04/01/2014CA2654318C Sulphimides as protein kinase inhibitors
04/01/2014CA2648019C Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
04/01/2014CA2628952C Aspartic protease inhibitors
04/01/2014CA2616377C Nitrocatechol derivatives as comt inhibitors
04/01/2014CA2604967C Pyrimidine derivatives and their use as p2y12 receptor antagonists
04/01/2014CA2581144C Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
03/2014
03/27/2014WO2014047393A1 N-substituted bis(fluoroalkyl)-1,4-benzodiazepinone compounds as notch inhibitors
03/27/2014WO2014047392A1 Fluoroalkyl-1,4-benzodiazepinone compounds
03/27/2014WO2014047374A1 Alkyl, fluoroalkyl-1,4-benzodiazepinone compounds
03/27/2014WO2014047372A1 Bis(fluoroalkyl)-1,4-benzodiazepinone compounds as notch inhibitors
03/27/2014WO2014047369A1 Substituted 1,5-benzodiazepinone compounds
03/27/2014WO2014047288A2 Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
03/27/2014WO2014047024A1 Iap antagonists
03/27/2014WO2014046544A1 Substituted 3-heteroaryloxy-3-(hetero)aryl-propylamines as serotonin transporter and serotonin ht2c receptor modulators
03/27/2014WO2014046125A1 Prevention/treatment agent for pulmonary hypertension comprising thrombin receptor antagonist as active component
03/27/2014WO2014045732A1 Metal complex and method for producing hydrogen peroxide
03/27/2014WO2014045031A1 Bicyclic aza compounds as muscarinic m1 receptor agonists
03/27/2014WO2014044846A1 3-(aryl- or heteroaryl-amino)-7-(3,5-dimethoxyphenyl)isoquinoline derivatives as fgfr inhibitors useful for the treatment of proliferative disorders or dysplasia
03/27/2014WO2014044107A1 Pyrazol[3,4-c] pyridine derivative, preparation method and use in medicine thereof
03/27/2014WO2014020555A3 Improved process for preparing dabigatran etexilate mesylate
03/27/2014WO2014020546A3 Crystalline forms of dabigatran etexilate and process for their preparation
03/27/2014WO2014020467A3 Process for the preparation of pyrazole substituted aminoheteroaryl compounds
03/27/2014WO2014019908A3 Substituted pyrroles active as kinases inhibitors
03/27/2014US20140088308 Fluoride-Releasing Compositions
03/27/2014US20140088156 Sorafenib derivatives as seh inhibitors
03/27/2014US20140088153 N-(3-carbamoylphenly)-1h-pyrazole-5-carboxamide derivatives and the use thereof for controlling animal pests
03/27/2014US20140088152 Composition for preventing and treating cardiovascular diseases, containing pyrazole derivative
03/27/2014US20140088151 Alhydroxymethyl biaryl benzotriazole derivatives
03/27/2014US20140088150 Cyclohexene benzotriazole derivatives
03/27/2014US20140088148 Small molecule inhibitors of xbp1 splicing
03/27/2014US20140088146 Heterocyclic compounds
03/27/2014US20140088141 Modulators of cystic fibrosis transmembrane conductance regulator
03/27/2014US20140088124 Imidazole derivatives
03/27/2014US20140088118 Heterocyclic compounds
03/27/2014US20140088112 Alkyne benzotriazole derivatives
03/27/2014US20140088099 Chemical compounds, compositions and methods for kinase modulation
03/27/2014US20140088097 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
03/27/2014US20140088094 N-SULFONYLATED TETRAHYDROQUINOLINES AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
03/27/2014US20140088085 Substituted Benzoazepines As Toll-Like Receptor Modulators
03/27/2014US20140088076 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
03/27/2014US20140088071 sGC STIMULATORS
03/27/2014US20140088046 Phenicol antibacterial agents
03/27/2014US20140088029 Novel pyrazole derivative
03/27/2014US20140087992 Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof
03/27/2014US20140086834 New i-arylpiperazinic ligands of 5-ht7 receptor and use thereof
03/26/2014EP2711361A1 Nitrogenated heterocyclic compound and agricultural or horticultural fungicide
03/26/2014EP2710018A2 New compounds
03/26/2014EP2710007A2 Kinase inhibitors
03/26/2014EP2709998A1 Substituted indole derivatives for the treatment of immunological disorders
03/26/2014EP2709997A1 Inhibitors of bruton's tyrosine kinase
03/26/2014EP2709996A1 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as vegf receptor kinase inhibitors
03/26/2014EP2709990A1 1-(arylmethyl)quinazoline-2,4(1h,3h)-diones as parp inhibitors and the use thereof
03/26/2014EP2709451A1 N-linked lactam m1 receptor positive allosteric modulators
03/26/2014CN203494211U Synchronous extraction and separation device for multiple ingredients of tobacco
03/26/2014CN103687855A Imidazole derivatives
03/26/2014CN103687854A Carbonic anhydrase targeting agents and methods of using same
03/26/2014CN103687853A Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use
03/26/2014CN103687852A 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as vegf receptor kinase inhibitors
03/26/2014CN103666459A Blue-fluorescence organic material and organic light emitting diode panel employing same
03/26/2014CN103664957A Compounds for treating narrow chamber angle and application thereof
03/26/2014CN103664935A Compounds for treating traumatic brain injury diseases and application thereof
03/26/2014CN103664909A Bicarbazole derivative, preparation method, application and organic light-emitting device
03/26/2014CN103664908A Aminopyrimidine heterocyclic compound having adenosine receptor antagonizing activity
03/26/2014CN103664896A Synthetic process method for novel antineoplastic molecular targeted drug of crizotinib
03/26/2014CN103664895A Pyridazinone compounds, preparation method thereof, medicinal composition and application thereof
03/26/2014CN103664894A 6H-naphtho-[2,1,8,7-klmn]Ar derivatives and application thereof
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 1080